Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-11-05 / Cancer 2016 Feb;122(3):367-77Immunotherapy for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-10-01 / Drug Discov Ther 2015 Oct;9(5):363-71Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-08-24 / Technol. Cancer Res. Treat. 2016 10;15(5):NP83-94Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-07-21 / J Immunother Cancer 2015;3:32Immunotherapy of hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2014-12-11 / Hepat Oncol 2014 Oct;1(4):433-446Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2014-08-15 / J. Natl. Cancer Inst. 2014 Aug;106(8)Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2014-07-24 / Oncol Lett 2014 Oct;8(4):1783-1787Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-6Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2013-06-24 / Technol. Cancer Res. Treat. 2014 Apr;13(2):169-75IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de